The BioCentury Show
The BioCentury Show
BioCentury
Ep. 99 – Stelios Papadopoulos on Biotech’s Long View: Pricing Pressure, China & Big Pharma
37 minutes Posted Dec 19, 2025 at 1:00 am.
Introduction
Financing Environment
Company Building
Women in Biotech
China, Korea & Europe
Is Biotech Too Insular?
0:00
37:59
Download MP3
Show notes
In historical terms, this is not a bear market, says Stelios Papadopoulos. There’s volatility, which is unnerving, and major issues to reckon with, but the level of anxiety in biotech doesn’t reflect the “extraordinary science, the likes of which we’ve never seen — and it’s getting better,” said Papadopoulos on The BioCentury Show. Papadopoulos is one of the long-term leading voices of biopharma, recognized for his influence in shaping the industry. Former chair of Biogen and current chair of...